DocuSign Selling And Marketing Expenses vs Ebit Analysis

DOCU Stock

USD 85.30 4.92 6.12%

DocuSign financial indicator trend analysis is much more than just examining DocuSign latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DocuSign is a good investment. Please check the relationship between DocuSign Selling And Marketing Expenses and its Ebit accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocuSign. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy DocuSign Stock please use our How to Invest in DocuSign guide.

Selling And Marketing Expenses vs Ebit

Selling And Marketing Expenses vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DocuSign Selling And Marketing Expenses account and Ebit. At this time, the significance of the direction appears to have very week relationship.

The correlation between DocuSign's Selling And Marketing Expenses and Ebit is 0.29. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Ebit in the same time period over historical financial statements of DocuSign, assuming nothing else is changed. The correlation between historical values of DocuSign's Selling And Marketing Expenses and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of DocuSign are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Selling And Marketing Expenses i.e., DocuSign's Selling And Marketing Expenses and Ebit go up and down completely randomly.

Correlation Coefficient

0.29

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Selling And Marketing Expenses

Ebit

Most indicators from DocuSign's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DocuSign current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DocuSign. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy DocuSign Stock please use our How to Invest in DocuSign guide.At this time, DocuSign's Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.19 in 2024, whereas Selling General Administrative is likely to drop slightly above 211.1 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	81.9M	86.3M	95.1M	63.5M
Interest Income	1.4M	4.5M	68.9M	72.3M

Depreciation And Amortization Interest Income

DocuSign fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		0.96	0.95	0.83	0.84	0.76	0.96	0.97	0.3	-0.95	0.66	0.92	1.0	0.71	0.9	0.98	0.98	0.99	0.93	0.94	-0.09	0.94	-0.93	0.99	0.86	0.94
Other Current Liab	0.96		0.95	0.72	0.76	0.6	0.98	0.97	0.28	-0.9	0.64	0.87	0.97	0.73	0.89	0.9	0.96	0.95	0.84	0.98	-0.04	0.86	-0.83	0.97	0.88	0.95
Total Current Liabilities	0.95	0.95		0.74	0.78	0.64	0.92	0.97	0.23	-0.89	0.57	0.91	0.94	0.79	0.9	0.92	0.98	0.92	0.84	0.92	-0.23	0.86	-0.8	0.96	0.84	0.93
Total Stockholder Equity	0.83	0.72	0.74		0.75	0.88	0.76	0.79	-0.09	-0.92	0.44	0.8	0.81	0.74	0.87	0.86	0.77	0.78	0.88	0.74	-0.45	0.95	-0.84	0.77	0.87	0.64
Other Liab	0.84	0.76	0.78	0.75		0.57	0.77	0.83	0.18	-0.86	0.69	0.86	0.83	0.58	0.78	0.84	0.83	0.87	0.88	0.7	-0.13	0.8	-0.76	0.8	0.71	0.75
Net Tangible Assets	0.76	0.6	0.64	0.88	0.57		0.66	0.65	0.1	-0.77	0.29	0.69	0.74	0.5	0.68	0.84	0.65	0.7	0.77	0.62	-0.27	0.87	-0.87	0.71	0.65	0.58
Property Plant And Equipment Net	0.96	0.98	0.92	0.76	0.77	0.66		0.95	0.35	-0.93	0.7	0.82	0.98	0.68	0.88	0.91	0.95	0.95	0.89	0.97	-0.01	0.89	-0.87	0.96	0.9	0.93
Current Deferred Revenue	0.97	0.97	0.97	0.79	0.83	0.65	0.95		0.18	-0.93	0.62	0.93	0.97	0.81	0.93	0.94	0.99	0.95	0.89	0.95	-0.18	0.89	-0.83	0.98	0.88	0.92
Net Debt	0.3	0.28	0.23	-0.09	0.18	0.1	0.35	0.18		-0.15	0.59	0.03	0.34	-0.29	-0.03	0.25	0.29	0.36	0.31	0.23	0.64	0.11	-0.35	0.3	0.02	0.42
Retained Earnings	-0.95	-0.9	-0.89	-0.92	-0.86	-0.77	-0.93	-0.93	-0.15		-0.69	-0.87	-0.95	-0.79	-0.96	-0.93	-0.93	-0.93	-0.93	-0.9	0.23	-0.97	0.9	-0.92	-0.94	-0.87
Accounts Payable	0.66	0.64	0.57	0.44	0.69	0.29	0.7	0.62	0.59	-0.69		0.44	0.69	0.39	0.59	0.58	0.69	0.73	0.7	0.64	0.33	0.58	-0.65	0.66	0.59	0.72
Cash	0.92	0.87	0.91	0.8	0.86	0.69	0.82	0.93	0.03	-0.87	0.44		0.89	0.74	0.87	0.94	0.9	0.91	0.84	0.82	-0.26	0.87	-0.81	0.91	0.76	0.83
Non Current Assets Total	1.0	0.97	0.94	0.81	0.83	0.74	0.98	0.97	0.34	-0.95	0.69	0.89		0.69	0.89	0.97	0.97	0.99	0.93	0.95	-0.04	0.93	-0.93	0.99	0.87	0.95
Non Currrent Assets Other	0.71	0.73	0.79	0.74	0.58	0.5	0.68	0.81	-0.29	-0.79	0.39	0.74	0.69		0.91	0.68	0.78	0.66	0.59	0.78	-0.48	0.76	-0.57	0.75	0.84	0.69
Other Assets	0.9	0.89	0.9	0.87	0.78	0.68	0.88	0.93	-0.03	-0.96	0.59	0.87	0.89	0.91		0.87	0.91	0.88	0.81	0.92	-0.29	0.94	-0.82	0.91	0.95	0.86
Cash And Short Term Investments	0.98	0.9	0.92	0.86	0.84	0.84	0.91	0.94	0.25	-0.93	0.58	0.94	0.97	0.68	0.87		0.94	0.96	0.93	0.88	-0.14	0.95	-0.95	0.96	0.81	0.89
Net Receivables	0.98	0.96	0.98	0.77	0.83	0.65	0.95	0.99	0.29	-0.93	0.69	0.9	0.97	0.78	0.91	0.94		0.96	0.89	0.95	-0.13	0.89	-0.85	0.99	0.87	0.96
Good Will	0.99	0.95	0.92	0.78	0.87	0.7	0.95	0.95	0.36	-0.93	0.73	0.91	0.99	0.66	0.88	0.96	0.96		0.91	0.92	0.03	0.91	-0.93	0.98	0.82	0.96
Common Stock Total Equity	0.93	0.84	0.84	0.88	0.88	0.77	0.89	0.89	0.31	-0.93	0.7	0.84	0.93	0.59	0.81	0.93	0.89	0.91		0.8	-0.18	0.9	-0.89	0.88	0.82	0.79
Common Stock Shares Outstanding	0.94	0.98	0.92	0.74	0.7	0.62	0.97	0.95	0.23	-0.9	0.64	0.82	0.95	0.78	0.92	0.88	0.95	0.92	0.8		-0.03	0.88	-0.84	0.96	0.91	0.95
Non Current Liabilities Total	-0.09	-0.04	-0.23	-0.45	-0.13	-0.27	-0.01	-0.18	0.64	0.23	0.33	-0.26	-0.04	-0.48	-0.29	-0.14	-0.13	0.03	-0.18	-0.03		-0.22	-0.04	-0.06	-0.33	0.11
Capital Surpluse	0.94	0.86	0.86	0.95	0.8	0.87	0.89	0.89	0.11	-0.97	0.58	0.87	0.93	0.76	0.94	0.95	0.89	0.91	0.9	0.88	-0.22		-0.95	0.91	0.9	0.84
Inventory	-0.93	-0.83	-0.8	-0.84	-0.76	-0.87	-0.87	-0.83	-0.35	0.9	-0.65	-0.81	-0.93	-0.57	-0.82	-0.95	-0.85	-0.93	-0.89	-0.84	-0.04	-0.95		-0.9	-0.77	-0.86
Other Current Assets	0.99	0.97	0.96	0.77	0.8	0.71	0.96	0.98	0.3	-0.92	0.66	0.91	0.99	0.75	0.91	0.96	0.99	0.98	0.88	0.96	-0.06	0.91	-0.9		0.84	0.96
Other Stockholder Equity	0.86	0.88	0.84	0.87	0.71	0.65	0.9	0.88	0.02	-0.94	0.59	0.76	0.87	0.84	0.95	0.81	0.87	0.82	0.82	0.91	-0.33	0.9	-0.77	0.84		0.79
Total Liab	0.94	0.95	0.93	0.64	0.75	0.58	0.93	0.92	0.42	-0.87	0.72	0.83	0.95	0.69	0.86	0.89	0.96	0.96	0.79	0.95	0.11	0.84	-0.86	0.96	0.79

Click cells to compare fundamentals

DocuSign Account Relationship Matchups

DocuSign fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.9B	2.3B	2.5B	3.0B	3.0B	2.0B
Other Current Liab	137.5M	222.7M	214.1M	264.1M	277.1M	142.5M
Total Current Liabilities	694.0M	1.1B	1.4B	2.2B	1.7B	1.0B
Total Stockholder Equity	546.3M	325.7M	275.5M	617.3M	1.1B	1.2B
Other Liab	23.1M	55.3M	49.3M	45.8M	52.6M	41.9M
Net Tangible Assets	294.9M	(146.2M)	(178.4M)	193.4M	222.4M	233.5M
Property Plant And Equipment Net	278.1M	324.4M	310.7M	341.4M	368.4M	227.6M
Current Deferred Revenue	507.6M	779.6M	1.0B	1.2B	1.3B	706.1M
Net Debt	407.3M	349.7M	373.2M	166.4M	(654.0M)	(621.3M)
Retained Earnings	(1.1B)	(1.4B)	(1.4B)	(1.6B)	(1.7B)	(1.8B)
Accounts Payable	28.1M	37.4M	52.8M	24.4M	19.0M	29.0M
Cash	241.2M	566.1M	509.1M	721.9M	797.1M	492.4M
Non Current Assets Total	947.2M	1.2B	1.2B	1.4B	1.4B	892.1M
Non Currrent Assets Other	24.7M	24.9M	362.2M	430.4M	509.2M	534.7M
Other Assets	162.5M	279.1M	362.2M	417.9M	480.6M	504.6M
Cash And Short Term Investments	656.1M	773.5M	802.8M	1.0B	1.0B	703.3M
Net Receivables	250.3M	340.5M	453.5M	529.4M	455.2M	309.8M
Good Will	194.9M	350.2M	355.1M	353.6M	353.1M	233.3M
Common Stock Total Equity	17K	18K	19K	20K	23K	15.7K
Common Stock Shares Outstanding	176.7M	185.8M	196.7M	200.9M	209.0M	185.0M
Liabilities And Stockholders Equity	1.9B	2.3B	2.5B	3.0B	3.0B	2.0B
Non Current Liabilities Total	650.8M	917.6M	894.1M	187.1M	180.9M	171.9M
Capital Surpluse	1.7B	1.7B	1.7B	2.2B	2.6B	2.7B
Inventory	16.6M	367K	280K	2.0	1.0	0.95
Other Current Assets	37.1M	48.4M	63.2M	70.0M	67.0M	41.9M
Other Stockholder Equity	1.7B	1.7B	1.7B	2.2B	2.8B	3.0B
Total Liab	1.3B	2.0B	2.3B	2.4B	1.8B	1.6B
Deferred Long Term Liab	153.3M	260.1M	311.8M	10.7M	12.3M	11.7M
Property Plant And Equipment Gross	278.1M	324.4M	310.7M	341.4M	612.6M	643.3M
Total Current Assets	943.9M	1.2B	1.3B	1.6B	1.6B	1.1B
Accumulated Other Comprehensive Income	(1.7M)	5.0M	(4.8M)	(23.0M)	(19.4M)	(18.4M)
Short Term Debt	20.7M	53.4M	74.8M	746.9M	44.5M	42.2M
Intangible Assets	56.5M	121.8M	98.8M	70.3M	50.9M	66.3M
Common Stock	17K	18K	19K	20K	21K	16.5K
Property Plant Equipment	278.1M	324.4M	310.7M	199.9M	229.9M	186.0M
Short Term Investments	414.9M	207.5M	293.8M	309.8M	248.4M	237.4M
Non Current Liabilities Other	6.7M	32.3M	23.3M	18.1M	21.3M	16.1M
Net Invested Capital	1.0B	1.0B	994.0M	1.3B	1.1B	1.1B
Net Working Capital	249.9M	69.2M	(52.0M)	(577.3M)	(93.0M)	(88.3M)
Short Long Term Debt Total	648.5M	915.8M	882.2M	888.3M	143.1M	135.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for DocuSign Stock Analysis

When running DocuSign's price analysis, check to measure DocuSign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocuSign is operating at the current time. Most of DocuSign's value examination focuses on studying past and present price action to predict the probability of DocuSign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocuSign's price. Additionally, you may evaluate how the addition of DocuSign to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC